111 related articles for article (PubMed ID: 11588112)
1. Reduction of oxidative stress and AT1 receptor expression by the selective oestrogen receptor modulator idoxifene.
Bäumer AT; Wassmann S; Ahlbory K; Strehlow K; Müller C; Sauer H; Böhm M; Nickenig G
Br J Pharmacol; 2001 Oct; 134(3):579-84. PubMed ID: 11588112
[TBL] [Abstract][Full Text] [Related]
2. Negative feedback regulation of reactive oxygen species on AT1 receptor gene expression.
Nickenig G; Strehlow K; Bäumer AT; Baudler S; Wassmann S; Sauer H; Böhm M
Br J Pharmacol; 2000 Oct; 131(4):795-803. PubMed ID: 11030730
[TBL] [Abstract][Full Text] [Related]
3. Nitric oxide stimulatory and endothelial protective effects of idoxifene, a selective estrogen receptor modulator, in the splanchnic artery of the ovariectomized rat.
Ma XL; Gao F; Yao CL; Chen J; Lopez BL; Christopher TA; Disa J; Gu JL; Ohlstein EH; Yue TL
J Pharmacol Exp Ther; 2000 Nov; 295(2):786-92. PubMed ID: 11046119
[TBL] [Abstract][Full Text] [Related]
4. C-reactive protein upregulates angiotensin type 1 receptors in vascular smooth muscle.
Wang CH; Li SH; Weisel RD; Fedak PW; Dumont AS; Szmitko P; Li RK; Mickle DA; Verma S
Circulation; 2003 Apr; 107(13):1783-90. PubMed ID: 12665485
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between aldosterone and angiotensin II in vascular smooth muscle cell senescence.
Min LJ; Mogi M; Iwanami J; Li JM; Sakata A; Fujita T; Tsukuda K; Iwai M; Horiuchi M
Cardiovasc Res; 2007 Dec; 76(3):506-16. PubMed ID: 17706954
[TBL] [Abstract][Full Text] [Related]
6. Insulin-like growth factor induces up-regulation of AT(1)-receptor gene expression in vascular smooth muscle cells.
Müller C; Reddert A; Wassmann S; Strehlow K; Böhm M; Nickenig G
J Renin Angiotensin Aldosterone Syst; 2000 Sep; 1(3):273-7. PubMed ID: 11881037
[TBL] [Abstract][Full Text] [Related]
7. Enhanced angiotensin receptor type 1 mRNA degradation and induction of polyribosomal mRNA binding proteins by angiotensin II in vascular smooth muscle cells.
Nickenig G; Murphy TJ
Mol Pharmacol; 1996 Oct; 50(4):743-51. PubMed ID: 8863818
[TBL] [Abstract][Full Text] [Related]
8. Interleukin-6 induces oxidative stress and endothelial dysfunction by overexpression of the angiotensin II type 1 receptor.
Wassmann S; Stumpf M; Strehlow K; Schmid A; Schieffer B; Böhm M; Nickenig G
Circ Res; 2004 Mar; 94(4):534-41. PubMed ID: 14699015
[TBL] [Abstract][Full Text] [Related]
9. Idoxifene: a novel selective estrogen receptor modulator prevents bone loss and lowers cholesterol levels in ovariectomized rats and decreases uterine weight in intact rats.
Nuttall ME; Bradbeer JN; Stroup GB; Nadeau DP; Hoffman SJ; Zhao H; Rehm S; Gowen M
Endocrinology; 1998 Dec; 139(12):5224-34. PubMed ID: 9832463
[TBL] [Abstract][Full Text] [Related]
10. Idoxifene causes endothelium-dependent, nitric oxide-mediated vasorelaxation in male rats.
Christopher TA; Lopez BL; Stillwagon JC; Gao F; Gao E; Ma XL; Ohlstein EH; Yue TL
Eur J Pharmacol; 2002 Jun; 446(1-3):139-43. PubMed ID: 12098595
[TBL] [Abstract][Full Text] [Related]
11. Upregulation of angiotensin II-AT1 receptors during statin withdrawal in vascular smooth muscle cells.
Castejon AM; Zollner E; Tristano AG; Cubeddu LX
J Cardiovasc Pharmacol; 2007 Dec; 50(6):708-11. PubMed ID: 18091590
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of geranylgeranylation reduces angiotensin II-mediated free radical production in vascular smooth muscle cells: involvement of angiotensin AT1 receptor expression and Rac1 GTPase.
Wassmann S; Laufs U; Bäumer AT; Müller K; Konkol C; Sauer H; Böhm M; Nickenig G
Mol Pharmacol; 2001 Mar; 59(3):646-54. PubMed ID: 11179461
[TBL] [Abstract][Full Text] [Related]
13. Angiotensin II down-regulates the vascular smooth muscle AT1 receptor by transcriptional and post-transcriptional mechanisms: evidence for homologous and heterologous regulation.
Lassègue B; Alexander RW; Nickenig G; Clark M; Murphy TJ; Griendling KK
Mol Pharmacol; 1995 Oct; 48(4):601-9. PubMed ID: 7476884
[TBL] [Abstract][Full Text] [Related]
14. Idoxifene antagonizes estradiol-dependent MCF-7 breast cancer xenograft growth through sustained induction of apoptosis.
Johnston SR; Boeddinghaus IM; Riddler S; Haynes BP; Hardcastle IR; Rowlands M; Grimshaw R; Jarman M; Dowsett M
Cancer Res; 1999 Aug; 59(15):3646-51. PubMed ID: 10446976
[TBL] [Abstract][Full Text] [Related]
15. Selective estrogen receptor modulator idoxifene inhibits smooth muscle cell proliferation, enhances reendothelialization, and inhibits neointimal formation in vivo after vascular injury.
Yue TL; Vickery-Clark L; Louden CS; Gu JL; Ma XL; Narayanan PK; Li X; Chen J; Storer B; Willette R; Gossett KA; Ohlstein EH
Circulation; 2000 Nov; 102(19 Suppl 3):III281-8. PubMed ID: 11082402
[TBL] [Abstract][Full Text] [Related]
16. Down-regulation of aortic and cardiac AT1 receptor gene expression in transgenic (mRen-2) 27 rats.
Nickenig G; Laufs U; Schnabel P; Knorr A; Paul M; Böhm MP
Br J Pharmacol; 1997 May; 121(1):134-40. PubMed ID: 9146897
[TBL] [Abstract][Full Text] [Related]
17. Idoxifene, a novel selective estrogen receptor modulator, is effective in a rat model of adjuvant-induced arthritis.
Badger AM; Blake SM; Dodds RA; Griswold DE; Swift BA; Rieman DJ; Stroup GB; Hoffman SJ; Gowen M
J Pharmacol Exp Ther; 1999 Dec; 291(3):1380-6. PubMed ID: 10565864
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation by growth factors of vascular smooth muscle angiotensin receptor gene expression.
Nickenig G; Murphy TJ
Mol Pharmacol; 1994 Oct; 46(4):653-9. PubMed ID: 7969043
[TBL] [Abstract][Full Text] [Related]
19. [Vasorelaxing effect of idoxifene on human internal mammary arteries].
Wei GZ; Yu J; Zhu YL; Lin SX; Kang YF; Wang R; Zhou JJ; Zhang QH
Sheng Li Xue Bao; 2004 Feb; 56(1):16-20. PubMed ID: 14985823
[TBL] [Abstract][Full Text] [Related]
20. Selective oestrogen receptor modulators/new antioestrogens: a clinical perspective.
Robertson JF
Cancer Treat Rev; 2004 Dec; 30(8):695-706. PubMed ID: 15541579
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
